Pharmafile Logo
Pharmafocus logo
Advanced Search
merckwindow_web

Merck joins Pizer and Novartis in reducing drug prices

July 20, 2018
Medical Communications Merck, Novartis, Pfizer, Trump, Twitter, price hikes

Merck & Co. have joined Pfizer and Novartis in halting price increases on medicines in the United States. The American …

News
donald_trump_29496131773

Donald Trump thanks Novartis for halting price hikes

July 20, 2018
Medical Communications Novartis, Pfizer, Trump, Twitter, price hikes

Donald Trump has thanked Swiss multinational Novartis for halting price hikes on prescription drugs in the United States. The US …

News

Novartis buys eczema drug in €95m deal

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, deal, eczema, experimental, patent

Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and …

News

PhRMA take on PBM’s in response to Trump drug price plan

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In response to Donald Trump’s plan to lower drug prices in the US, the Pharmaceutical Research and Manufacturers of America …

News
28246711066_52e38bc591_z

MPs vote to stay in EMA after Brexit

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, UK, brexit, parliament, vote

British MPs have voted for the UK’s continued participation in the regulatory network operated by the European Medicines Agency (EMA) …

News
800px-bill_og_melinda_gates_2009-06-03_bilde_01

Bill Gates commits $30m towards Alzheimer’s diagnostic test

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis

Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …

News
janssen_latest_logo_on_sign

Janssen’s Symtuza scores approval with the FDA in HIV-1

July 18, 2018
Sales and Marketing HIV, Janssen, Symtuza, pharma

Janssen has announced that Symtuza (D/C/F/TAF) has received approval from the FDA in the treatment of human immunodeficiency virus type …

News
astrazeneca_plaque

AstraZeneca increases drug stockpile in preparation for no-deal Brexit

July 18, 2018
Research and Development AstraZeneca, brexit, no-deal, pharma, stockpiling

The Anglo-Swedish drug giant AstraZeneca is set to increase its stockpile of drugs in both the United Kingdom and the …

News
shutterstock_138095450

Novartis follows Pfizer’s lead, pledges no price hikes in 2018

July 18, 2018
Research and Development, Sales and Marketing Novartis, Pfizer, President trump, Trump, US, pharma

Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the …

News
administration_building_mclean_hospital_belmont_ma

Researchers develop algorithm able to identify antidepressant suitability

July 18, 2018
Research and Development McLean, algorithm, antidepressants, research

A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm …

News
humira_abbott__4

AbbVie and Mylan reach US marketing agreement for Humira biosimilar

July 18, 2018
Research and Development, Sales and Marketing AbbVie, Humira, Mylan, US, pharma

AbbVie and Mylan have announced that they have both signed a licensing agreement for the former’s proposed biosimilar version of …

News
nazneen-rahman-credit-the-royal-marsden-embed

Renowned cancer researcher leaves ICR over bullying allegations

July 17, 2018
Research and Development

Leading geneticist and cancer researcher, Nazneen Rahman CBE, has resigned from her position as head of Genetics and Epidemiology at …

News
david_horn_solomon

Silence Therapeutics appoints ex-Akari CEO in top position

July 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …

Appointment
diabetes-777001_960_720

Researchers successfully minimise diabetes drug side-effects in animal models

July 17, 2018
Manufacturing and Production, Research and Development FDA, diabetes, pharma, type 2 diabetes

Researchers at the University of Pennsylvania and Syracuse University have modified a key ingredient of current diabetes drugs to produce …

News

Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?

July 17, 2018
Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma

Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …

News
jj_sign_on_wall

J&J stops Invokana trial early after success in kidney disease and type 2 diabetes

July 17, 2018
Manufacturing and Production, Research and Development J&J, JJ, Janssen, Johnson & Johnson, invokana, kidney disease, pharma, renal, type 2 diabetesm diabetes

Johnson & Johnson and research arm Janssen have taken the decision to terminate a Phase 3 trial evaluating the efficacy …

News
5204602349_c87b204860_z

FDA cautions consumers on fake warning letter scam

July 17, 2018
Manufacturing and Production FDA, fake, letter, scam, warning

The FDA has warned that criminals have been targeting customers who bought medicines online or over the phone with “official-looking, …

News

CRISPR gene editing may frequently cause undetected genetic damage

July 17, 2018
Manufacturing and Production DNA, crispr, gene editing, genetic damage

Scientists studying the gene editing technology CRISPR-Cas9 have discovered the technique appears to frequently cause genetic damage that may slip …

News
489px-trump_executive_michael_cohen_013_cropped

Senate claims Novartis misled public on Trump lawyer deal

July 16, 2018
Sales and Marketing Novartis, Senate, Trump, United States, deal

A report released by the United States Senate has found that Novartis’ relationship with Donald Trump’s long-time lawyer Michael Cohen …

News
patient_graphic

Recruitment and retention: How can we do better?

July 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, patient recruitment, patients, pharma

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt …

Feature
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026